| 1009. Venous 1: A Prospective Multicenter Cohort Study of Enterococcal Bacteremia G Contreras, JM Munita, KC Reyes, P Sahasrabhojane, H Misikir, ... Open Forum Infectious Diseases 5 (suppl_1), S300-S300, 2018 | | 2018 |
| Longitudinal Sensitivity of the MD Anderson Symptom Inventory for Acute Myeloid Leukemia LA Williams, TY Chen, DP Kontoyiannis, JR Galloway-Pena, ... Blood 132 (Suppl 1), 4825-4825, 2018 | 2 | 2018 |
| 1055. Epidemiology and Mechanisms of Carbapenem Resistance in Recurrent Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae Bacteremia SL Aitken, M Bhatti, P Sahasrabhojane, J Galloway-Pena, X Li, ... Open Forum Infectious Diseases 5 (Suppl 1), S315, 2018 | | 2018 |
| Associations of inflammation with symptom burden in patients with acute myeloid leukemia TE Lacourt, A Kavelaars, JR Galloway-Peña, PV Sahasrabhojane, ... Psychoneuroendocrinology 89, 203-208, 2018 | 12 | 2018 |
| Characterization of oral and gut microbiome temporal variability in hospitalized cancer patients JR Galloway-Peña, DP Smith, P Sahasrabhojane, WD Wadsworth, ... Genome medicine 9 (1), 21, 2017 | 101 | 2017 |
| A Prospective Study of Enterococcal Bacteremia in Cancer vs.. Non-Cancer Populations: One Disease, Two Tales JM Munita, G Contreras, P Sahasrabhojane, GS Petitto, R Araos, ... Open Forum Infectious Diseases 4 (suppl_1), S546-S546, 2017 | | 2017 |
| Whole-Genome Sequencing Accurately Identifies Resistance to Extended-Spectrum β-Lactams for Major Gram-Negative Bacterial Pathogens SA Shelburne, J Kim, JM Munita, P Sahasrabhojane, RK Shields, ... Clinical Infectious Diseases 65 (5), 738-745, 2017 | 68 | 2017 |
| Use of a phosphorylation site mutant to Identify distinct modes of gene repression by the control of virulence regulator (CovR) in Streptococcus pyogenes N Horstmann, P Sahasrabhojane, H Yao, X Su, SA Shelburne Journal of bacteriology, JB. 00835-16, 2017 | 15 | 2017 |
| Identification and Whole Genome Sequencing of the First Case of Kosakonia radicincitans causing a human bloodstream infection MD Bhatti, A Kalia, P Sahasrabhojane, J Kim, DE Greenberg, ... Frontiers in microbiology 8, 62, 2017 | 23 | 2017 |
| The role of the gastrointestinal microbiome in infectious complications during induction chemotherapy for acute myeloid leukemia JR Galloway‐Peña, DP Smith, P Sahasrabhojane, NJ Ajami, ... Cancer 122 (14), 2186-2196, 2016 | 146 | 2016 |
| Complete genome sequence of Streptococcus mitis strain SVGS_061 isolated from a neutropenic patient with viridans group streptococcal shock syndrome V Petrosyan, M Holder, NJ Ajami, JF Petrosino, P Sahasrabhojane, ... Genome announcements 4 (2), e00259-16, 2016 | 7 | 2016 |
| Sequence type 1 group B Streptococcus, an emerging cause of invasive disease in adults, evolves by small genetic changes AR Flores, J Galloway-Peña, P Sahasrabhojane, M Saldaña, H Yao, X Su, ... Proceedings of the National Academy of Sciences, 201504725, 2015 | 96 | 2015 |
| Characterization of the effect of the histidine kinase CovS on response regulator phosphorylation in group A Streptococcus N Horstmann, P Sahasrabhojane, M Saldaña, NJ Ajami, AR Flores, ... Infection and immunity, IAI. 02659-14, 2015 | 45 | 2015 |
| 125Single Nucleotide Polymorphisms Drive Phenotypic Diversity Among Sequence Type 1 Group B Streptococcus, An Emerging Cause of Invasive Disease in … J Galloway-Pena, P Sahasrabhojane, I Margarit, R Rosini, G Grandi, ... Open Forum Infectious Diseases 1 (suppl_1), S12-S12, 2014 | | 2014 |
| GyrB polymorphisms accurately assign invasive viridans group streptococcal species J Galloway-Peña, P Sahasrabhojane, J Tarrand, XY Han, SA Shelburne Journal of clinical microbiology, JCM. 01068-14, 2014 | 19 | 2014 |
| Species-level assessment of the molecular basis of fluoroquinolone resistance among viridans group streptococci causing bacteraemia in cancer patients P Sahasrabhojane, J Galloway-Peña, L Velazquez, M Saldaña, ... International journal of antimicrobial agents 43 (6), 558-562, 2014 | 17 | 2014 |
| Dual-site phosphorylation of the control of virulence regulator impacts group a streptococcal global gene expression and pathogenesis N Horstmann, M Saldaña, P Sahasrabhojane, H Yao, X Su, E Thompson, ... PLoS pathogens 10 (5), e1004088, 2014 | 72 | 2014 |
| Streptococcus mitis strains causing severe clinical disease in cancer patients SA Shelburne, P Sahasrabhojane, M Saldana, H Yao, X Su, N Horstmann, ... Emerging infectious diseases 20 (5), 762, 2014 | 160 | 2014 |
| Development and validation of a clinical model to predict the presence of β-lactam resistance in viridans group streptococci causing bacteremia in neutropenic cancer patients SA Shelburne III, RE Lasky, P Sahasrabhojane, JT Tarrand, KVI Rolston Clinical Infectious Diseases 59 (2), 223-230, 2014 | 45 | 2014 |
| Development and Validation of a Clinical Model to Predict the Presence of β-lactam Resistance in Viridans Group Streptococci Causing Bacteremia in Neutropenic Cancer Patients SAS III, R Lasky, P Sahasrabhojane, JT Tarrand, KVI Rolston | | 2014 |
